Vanguard Group
TELO icon

Vanguard Group’s Telomir Pharmaceuticals TELO Stock Holding History

Vanguard Group’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.51M Buy
1,137,466
+35,714
+3% +$51.5K ﹤0.01% 3648
2025
Q3 		$1.53M Sell
1,101,752
-16,474
-1% -$24.8K ﹤0.01% 3656
2025
Q2 		$1.4M Sell
1,118,226
-139,964
-11% -$324K ﹤0.01% 3653
2025
Q1 		$4.06M Sell
1,258,190
-10,564
-0.8% -$46.2K ﹤0.01% 3251
2024
Q4 		$5.23M Buy
1,268,754
+117,227
+10% +$552K ﹤0.01% 3249
2024
Q3 		$7.39M Buy
1,151,527
+1,122,847
+3,915% +$5.47M ﹤0.01% 3105
2024
Q2 		$138K Buy
+28,680
New +$179K ﹤0.01% 4201

Other funds holding TELO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Vanguard Group's TELO Position: Q4 2025 in Review

Vanguard Group increased its Telomir Pharmaceuticals (TELO) stake by 3.2% in Q4 2025, buying an estimated $51.5K and bringing the position to 1,137,466 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #3648.

Vanguard Group first reported a position in TELO in Q2 2024 and has held it in 7 quarters since. The position peaked at $7.39M in Q3 2024. 33 funds tracked by Wall St. Rank hold TELO as of Q4 2025.

  • Vanguard Group held 1,137,466 shares of Telomir Pharmaceuticals worth $1.51M as of Q4 2025.
  • Vanguard Group bought 35,714 Telomir Pharmaceuticals shares in Q4 2025, an estimated $51.5K.
  • Telomir Pharmaceuticals made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3648 holding.
  • Vanguard Group first reported a position in Telomir Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • Vanguard Group's Telomir Pharmaceuticals position peaked at $7.39M in Q3 2024.
  • 33 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.